Related Experiment Video

Updated: Jun 12, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

p16(INK4a) -mediated suppression of telomerase in normal and malignant human breast cells

Alexey V Bazarov1, Marjolein Van Sluis, William C Hines

  • 1Department of Laboratory Medicine, University of California, San Francisco, USA.

Aging Cell
|June 24, 2010
PubMed

Insights

The tumor suppressor p16 (CDKN2A) not only stops cell division but also permanently silences the hTERT gene in breast cells. This repression, mediated by epigenetic changes, offers a new strategy against cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • The cyclin-dependent kinase inhibitor p16(INK4a) (CDKN2A) is a crucial tumor suppressor gene.
  • p16 induces cellular senescence, an irreversible cell cycle arrest, to prevent cancer development.

Purpose of the Study:

  • To investigate an additional anti-oncogenic function of p16 beyond cell cycle arrest.
  • To determine if p16 can repress the human telomerase reverse transcriptase (hTERT) gene.

Main Methods:

  • Transient expression of p16 in normal and malignant breast epithelial cells.
  • Analysis of hTERT gene expression and epigenetic modifications at its promoter.
  • Investigation of histone modifications, specifically H3K27 trimethylation.

Main Results:

  • Transient p16 expression led to stable repression of the hTERT gene in breast epithelial cells.
  • p16 increased H3K27 trimethylation at the hTERT promoter, causing transcriptional silencing.
  • This silencing is likely mediated by polycomb complexes.

Conclusions:

  • p16 exhibits a novel anti-oncogenic mechanism by irreversibly repressing the hTERT gene.
  • Transient p16 exposure may prevent malignant progression by silencing genes essential for self-renewal, like hTERT.
  • This finding suggests potential therapeutic strategies targeting epigenetic regulation by p16.

More Related Videos

Processing of Human Reduction Mammoplasty and Mastectomy Tissues for Cell Culture13:08

Processing of Human Reduction Mammoplasty and Mastectomy Tissues for Cell Culture

Published on: January 3, 2013

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...